Acurx Pharmaceuticals (ACXP)
NASDAQ:ACXP
Holding ACXP?
Track your performance easily

Acurx Pharmaceuticals (ACXP) Financial Statements

122 Followers

Acurx Pharmaceuticals Financial Overview

Acurx Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.162; its P/E ratio is -1.60; Acurx Pharmaceuticals is scheduled to report earnings on November 13, 2024, and the estimated EPS forecast is $-0.14. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -4.12M$ -4.38M$ -5.11M$ -3.11M$ -3.45M
EBITDA$ -4.12M$ -4.38M$ -5.11M$ -3.11M$ -3.45M
Net Income Common Stockholders$ -4.12M$ -4.38M$ -5.11M$ -3.12M$ -3.45M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 6.40M$ 8.90M$ 7.50M$ 7.10M$ 9.10M
Total Assets$ 6.58M$ 9.11M$ 7.71M$ 7.16M$ 9.19M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -6.40M$ -8.90M$ -7.50M$ -7.10M$ -9.10M
Total Liabilities$ 3.15M$ 3.11M$ 3.04M$ 3.22M$ 3.02M
Stockholders Equity$ 3.43M$ 6.00M$ 4.67M$ 3.93M$ 6.22M
Cash Flow-
Free Cash Flow$ -2.88M$ -3.06M$ -4.20M$ -2.09M$ -1.58M
Operating Cash Flow$ -2.88M$ -3.06M$ -4.20M$ -2.09M$ -1.58M
Investing Cash Flow-----
Financing Cash Flow$ 320.21K$ 4.51M$ 4.62M-$ 3.54M
Currency in USD

Acurx Pharmaceuticals Earnings and Revenue History

Acurx Pharmaceuticals Debt to Assets

Acurx Pharmaceuticals Cash Flow

Acurx Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis